Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 117.67M P/E - EPS this Y - Ern Qtrly Grth -
Income 19.61M Forward P/E - EPS next Y - 50D Avg Chg -4.00%
Sales 661.15k PEG - EPS past 5Y - 200D Avg Chg -31.00%
Dividend N/A Price/Book 1.26 EPS next 5Y - 52W High Chg -69.00%
Recommedations - Quick Ratio 5.55 Shares Outstanding 17.64M 52W Low Chg 9.00%
Insider Own 28.12% ROA -23.24% Shares Float 12.03M Beta 2.25
Inst Own 5.40% ROE 50.30% Shares Shorted/Prior 120.56K/65.79K Price 1.85
Gross Margin 100.00% Profit Margin 2,966.07% Avg. Volume 124,280 Target Price -
Oper. Margin -2,155.76% Earnings Date Sep 30 Volume 35,233 Change -2.44%
About Incannex Healthcare Limited

Incannex Healthcare Inc., a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications. The company offers APIRx-1801, an ultrapure tetrahydrocannabinol; APIRx-1802, an ultrapure CBD; and APIRx-1803, an ultrapure cannabigerol. It also develops IHL-42X, which has completed Phase IIb clinical trial for obstructive sleep apnea; Psi-GAD that is in Phase IIa clinical trial for generalized anxiety disorder; MedChew Dronabinol, which has completed Phase Ia clinical trial for nausea and vomiting in chemotherapy; CanChew Plus that has completed Phase IIa clinical trial for irritable bowel syndrome; APIRx-1601, which has completed Phase IIa clinical trial for vitiligo; APIRx-1602 skin that has completed Phase IIa clinical trial for psoriasis; and APIRx-1603, which has completed Phase IIa clinical trial for atopic dermatitis. In addition, its product portfolio includes IHL-675A for inflammatory lung disease, IHL-675A for rheumatoid arthritis, IHL-675A for inflammatory bowel disease, and IHL-216A for traumatic brain injury and concussion, which have completed pre-clinical trials; and MedChew 1401 for pain and spasticity in multiple sclerosis, MedChew GB for post-herpatic neuralgia, MedChew-1502 for Parkinson's disease, MedChew-1503 for dementia, MedChew RL for restless legs syndrome, APIRx 1505 Flotex for chrohn's disease, CanChew RX and SuppoCan (Suppository) for inflammatory bowel disease, CheWell for addiction of cannabis, CanQuit for tobacco smoking cessation, CanQuit O for opioid addiction, APIRx-1701 for glaucoma, suppoCan gastro for IBD, and APIRx-1702 for dry eye syndrome that are in pre-clinical trials. Incannex Healthcare Inc. was incorporated in 2001 and is based in Sydney, Australia.

Incannex Healthcare Limited News
12/02/24 Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025
11/14/24 Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates
10/24/24 Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer
10/22/24 Incannex Healthcare Leads The Charge On US Penny Stocks With 2 Other Notable Picks
10/02/24 Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL)
09/30/24 Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates
09/10/24 Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors
09/09/24 Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives
08/05/24 FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed
07/30/24 Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X
05/30/24 Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea
05/07/24 Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder
05/01/24 Stonegate Healthcare Partners Releases Report on Potentially Transformative Therapies for Generalized Anxiety Disorder (GAD)
04/16/24 Incannex Healthcare Inc. Quarterly Update, Q1 2024
02/28/24 Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder
02/16/24 Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation
02/01/24 Clarion Clinics Open for Psychedelic-Assisted Treatments
01/24/24 Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis
01/18/24 Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences
01/17/24 Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea
IXHL Chatroom

User Image EPR53167 Posted - 12/31/24

$IXHL One of my top two picks for January Effect upswing - along with IBG.

User Image EPR53167 Posted - 12/30/24

$IXHL $2$2$2$2$2$2$2$2$2$2$2$2

User Image jmcekc Posted - 12/27/24

$IXHL News next week! Hoping at least.

User Image EPR53167 Posted - 12/20/24

$IXHL Another 5K @ $1.73. When this blows up in January, will be a happy day :)

User Image EPR53167 Posted - 12/18/24

$IXHL Up 25% in eight sessions is nice, but we need VOLUME!! $2$2$2$2$2$2$2$2$2$2$2$2$2$2$2$2

User Image jmcekc Posted - 12/13/24

$IXHL News? Where are you news!!!????

User Image EPR53167 Posted - 12/12/24

$IXHL Decent 15% bounce these last few days but on light volume. This is a very legit biotech with a lot of promise trading at a very low valuation. Was $8+ in March FYI.

User Image newsfile_corp Posted - 1 month ago

https://nfne.ws/232235 $IXHL @reportablenews #NASDAQ #Investing

User Image EPR53167 Posted - 11/21/24

$IXHL Added another 2500 @ $1.96 on pullback from $3.12 seven sessions ago. Screaming buy here…

User Image Lesbn Posted - 11/17/24

$IXHL Just had a Quick Look, looks like the MJ index fund sold their last bit of stock at 2.05. They now hold zero. Would expect a bounce here, DYOR, this will be quicker than one of Elons Rockets when it goes!

User Image EPR53167 Posted - 11/15/24

$IXHL Averaged down $2.18 on drop from $2.65 this am and $3.12 on Tuesday.

User Image VeryLong Posted - 11/14/24

$IXHL nice business update. https://www.globenewswire.com/news-release/2024/11/14/2981582/0/en/Incannex-Healthcare-Inc-Reports-Fiscal-First-Quarter-2025-Financial-Results-and-Business-Updates.html

User Image EPR53167 Posted - 11/14/24

$IXHL Tripled up @ $2.35 on pullback from $3.12 Tuesday.

User Image FallofthePhoenix Posted - 11/14/24

$ATAI $IXHL $CYBN $MNMD as a person that deals with depression an anxiety, I will invest every penny I have into this. I have self medicated on my own with microdosing and it is a f*cking miracle. I never liked the side effects of anti depressants so I stopped taking them years ago but thanks to the magical shrooms I don’t have to deal with depression or side effects from all those bad meds out there. Don’t take my word for it. I HIGHLY (no pun intended) recommend trying this for yourself. And don’t be scared because you can’t even tell you have taken any until after a few weeks and then it hits you that you have slowly transitioned out of depression. I would recommend a full blown trip though to get everything kick started. You won’t be disappointed. Your perspective on EVERYTHING will change for the better. GLTA and let’s make some damn money……

User Image cryptoambassador Posted - 11/13/24

$IXHL Loading up on this one 🐳

User Image FallofthePhoenix Posted - 11/13/24

$IXHL I was hoping for at least one last dip 😁

User Image Tossydog Posted - 11/13/24

$ATAI great to see the sector starting to gain interest. $IXHL is another who will benefit, with clinical trials for General Anxiety Disorder using psilocybin & a clinic called Clarion Clinics already up & running in Australia. A head of the game. www.clarionclinics.com

User Image csnds Posted - 11/12/24

$IXHL This thing is going to blast off soon. give us a little volume and its going to $80

User Image EPR53167 Posted - 11/12/24

$IXHL All she needs is some volume and she GONE!

User Image 2HP Posted - 11/12/24

$IXHL Krass

User Image jmcekc Posted - 11/11/24

$IXHL BULLISH!!

User Image EPR53167 Posted - 11/11/24

$IXHL Has “that look” - high print since early July. Have long posted that this is one of the most underpriced biotechs out there with exceptional upside potential - maybe now folks are finally figuring out I was right ;)….

User Image jmcekc Posted - 11/10/24

$IXHL I feel like a big week is coming! Hope I am right.

User Image Tossydog Posted - 11/09/24

$IXHL Ichimoku Traders - $IXHL Screaming BUY. Lagging Span indicator confirmed. Trend Traders - $IXHL Screaming BUY. Higher Highs, Higher Lows. Fundamental Traders - $IXHL Screaming BUY. Money available & late stage clinical assets #ichimokutraders #trendtraders #fundamentaltrader

User Image Tossydog Posted - 11/08/24

$PSIL holding $IXHL- good job . There is plenty of blue sky above for $IXHL. Will be one of its biggest holding as it grows.

User Image 2HP Posted - 11/08/24

$IXHL still cheap 🫣

User Image FallofthePhoenix Posted - 11/08/24

$IXHL man those trials must be going great😁

User Image jmcekc Posted - 11/08/24

$MNMD Train is leaving the station! Loaded up two days ago. Also love $CYBN and $IXHL

User Image jmcekc Posted - 11/07/24

@PsychedStocks Agree! This is just the beginning. Also like $IXHL $CYBN $MNMD $CMPS

User Image _www_larval_com_ Posted - 1 month ago

$IXHL just stumbled -10% lower to -5% (~30Kv) moments ago, follow for more volatility.